In the News


Crumb Rubber Fields – An Emerging Mass Tort?

Bloomberg News recently interviewed my law partner Doug Daniels and I for an article entitled “Playing Fields and Cancer – An Emerging Mass Tort?”  The article examines whether crumb rubber synthetic playing fields could be the next mass tort considering the effects these fields have on public health and the environment.  The chance...

Johnson & Johnson Ordered to Pay $55 Million in Talcum Powder Trial

Johnson & Johnson was ordered by a U.S. jury on Monday to pay $55 million to a woman who said that using the company’s talc-powder products for feminine hygiene caused her to develop ovarian cancer. The verdict, which J&J plans to appeal, was the second straight trial loss for the company, which is facing about 1,200 lawsuits accusi...

Health Concerns Over Crumb Rubber Fields Have Schools Worried

Crumb Rubber fields continue to be newsworthy as the following article demonstrates.  It appeared in the Chicago-Tribune on April 14, 2016.  It is curious that Field Turf, one of the largest manufacturers and proponents of Crumb Rubber fields, no longer installs Crumb Rubber.  The question is why.  What does Field Turf know or susp...

Fresenius Settles All Granuflo Claims for $250 Million

Fresenius Medical Care agrees to pay $250 million to resolve U.S. litigation related to its GranuFlo and NaturaLyte products. Under the terms of the agreement, 97% of the plaintiffs must agree to the settlement by July 2016 to receive funding in August 2016. Insurers will pay $220M (88%) of the total settlement amount.The company inten...

CA Judge Allows Paralyzed Player’s Claim Against Pop Warner to Continue

Is this the beginning of the end for youth tackle football? It certainly could be. A cultural sea change appears to be happening regarding our country’s true national pastime. In what may be considered a major shift in legal liability, “a California judge has ruled that a teenage football player who was paralyzed by an on-field hit...

Harvard Study Suggests Link Between E-Cigarettes and Lung Disease

E-cigarettes are coming.  Some say they are already here.  Especially if you visit an average high school parking lot after school. USA Today article on E-Cigarettes states how flavored e-cigarettes may seem like an alternative to smoking, but researchers warn that flavored e-cigarettes may not be worth the unknown long-term risks. R...

VOLKSWAGEN UPDATE: MORE CARS MAY BE AFFECTED

The New York Times and other media outlets are reporting that more Volkswagen cars than originally thought may be affected with the cheating emissions software. Originally, only cars and light commercial vehicles equipped with a diesel motor line known as the EA 189 had the illegal software.  However, Volkswagen said it was investigat...

UPDATE: Actos Settlement Reportedly Hits 97% Threshold

Enough claimants have signed on to trigger a $2.4 billion payment from Takeda Pharmaceuticals to settle a large dose of the litigation pending against the drugmaker over the alleged negative effects of its Actos diabetes drug, lawyers for thousands of the plaintiffs have announced. On Oct. 7, Meyers & Flowers, a law firm based in St. C...

New Volkswagen CEO Says Emissions Scandal Could Signal the End of the Company

USA Today is reporting that Volkswagen’s new CEO, Hans Dieter Poetsch, admits how the Volkswagen emissions scandal could cripple the world’s largest automaker to the point that it is forced to shut down. Poetsch warned managers how the automaker’s diesel-emission scandal poses “an existence-threatening crisis for the company” as ne...

More than 96% of Claimants Opt-In to ACTOS Resolution Program

FiercePharma is reporting that Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. (collectively “Takeda”), today announced that more than 96 percent of eligible claimants have opted into the ACTOS (pioglitazone HCl) product liability resolution program that was announced on Apri...

Boston Scientific Ordered to Pay in Settlement Over Mesh

Disclaimer: Results of this case are not necessarily indicative of future cases. A Delaware jury awarded a 51-year old bank teller $100 million over physical and emotional injuries she sustained from Boston Scientific’s vaginal mesh inserts. The $100 million settlement, one of the largest jury verdicts of 2015, consists of $25 millio...

NEWS FLASH: Depakote Jury Reaches Verdict in Spina Bifida Case

Disclaimer: Results of this case are not necessarily indicative of future cases. A stunning development out of St. Louis where a jury awarded a 12-year-old plaintiff Maddision Schmidt $15 million in compensatory damages and $23 million in punitive damages for birth defects she suffered from her mother taking Depakote while pregnant. Th...

First Tylenol Bellwether Trial Set for June 22, 2015

The first Tylenol bellwether trial in multidistrict litigation (MDL) is fast approaching and lawyers from both sides are gearing up. The Pennsylvania trial involves whether the acetaminophen in various Tylenol products from Johnson & Johnson (J&J), and its subsidiary McNeill Consumer Healthcare, caused acute liver failure. U.S. Distric...

NY AG Takes the Lead and Sues 2 Tanning Salons for Deceptive Advertising

50 years in the future, I’m certain people will look back and wonder what we were thinking about the unchecked proliferation of indoor tanning salons much like we modern, enlightened people look back on those cigarette ads from the 1930s that promoted healthly living. Finally, someone in a legal position of authority is doing something...

Promise I’m NOT Blowing Smoke: Competitive E-Cigarette Smoking

I promise I’m not making this up. Grown men, seemingly employed grown men, actually compete to see who has the biggest smoke plume from an e-cigarette drag. Really? It’s called “cloud chasing” or “competitive vaping” reports The Wall Street Journal. “Competitive” as if it’s a sport. Kind of like darts is a sport. Or b...

E-Cigarettes Increasingly Popular with Teens

E-Cigarette use has risen sharply over the past few years, as reported by the New York Times. E-cigarette use has tripled among middle and high school students from 2013 to 2014. According to federal data released today, 13% of high school students smoke e-cigarettes. As our T&T blog has reported on in the past, the Food and Drug Admin...

Bellwether Trial Begins in St. Louis over Pfizer’s Zoloft

On Thursday, April 9, 2015, trial began in St. Louis, Missouri over Pfizer’s Zoloft, the company’s antidepressant drug, before Circuit Court Judge Margaret Neill. The Plaintiffs, Logyn Pesante and his mother Kristyn Pesante, allege that Zoloft caused Logyn Pesante to be born with multiple heart defects including TGA, or transpositi...

Study Shows Tylenol No Better Than Placebo & Hard on Your Liver

The New York Times reported on April 1, 2015 that Tylenol is no better than a placebo when given to patients seeking relief from spinal pain or disability. The Australian researchers, published online in The BMJ, analyzed 5, 366 patients. Acetaminophen (Tylenol) was given orally in doses between 3,000-4,000 milligrams per day. What is ...

ACTOS UPDATE: Takeda Offers Massive Settlement for Actos Users

Bloomberg News is reporting that Takeda Pharmaceutical Co., Asia’s largest drugmaker, is offering a $2.2 billion settlement for the 8,000 Actos lawsuits filed in state and federal courts throughout the U.S. On an individual basis, the settlement amount figures to be $275,000 per lawsuit. As the T&T blog has reported in the past, Acto...

Dialysis GranuFlo Litigation Update

The T&T blog has reported on the Dialysis Litigation in the past as T&T represents hundreds of clients who were injured as a result of Fresenius Medical Care use of GranuFlo and NaturaLyte. Here is an update for all of our dialysis clients out there: The first bellwether trails for the Dialysis Litigation is scheduled for January 11th,...

Study Shows Teens Easily Purchase E-Cigarettes Over the Internet

March 2015’s issue of JAMA Pediatrics published a study entitled “Electronic Cigarette Sales to Minors via the Internet.” From February to June 2014, 11 teenagers from North Carolina ranging from 14 to 17 years old made supervised e-cigarette purchase attempts from 98 Internet e-cigarette vendors. The results are not a surprise t...

Judge Rules in Favor of DOJ in American Express Case

Many news outlets including The New York Times, Bloomberg, and USA Today are reporting that after a seven-week trial U.S. Federal District Judge Garaufis ruled in favor of the DOJ in its claim that American Express violated U.S. anti-trust laws.  In the 150-page opinion, Garaufis wrote how American Express successfully pressured merc...

Indoor Tanning Industry Braces as New Longterm Risks Continue to Emerge

As the United States continues through a winter that included a historic blizzard in the Northeast, many of us may be longing for summer days spent on the beach, soaking up the sun and working on a tan. A number of people, however, may not bother waiting until summer and will instead visit one of the approximately 14,000 tanning salons...

J&J Drops Plaintiff Solicitation Discovery Bid In Mesh MDL

Johnson & Johnson has withdrawn its discovery motion to pursue its allegations that the plaintiffs’ attorneys in transvaginal mesh multidistrict litigation had engaged in illegal plaintiff solicitation and filed lawsuits without legitimate claims. U.S. District Judge Joseph Goodwin on Feb. 11 granted J&J’s motion to withdraw its discov...

Takeda Told to Pay Punitive Damages in Actos Claims

A jury ordered Takeda Pharmaceutical Co. to pay $1.3 million in punitive damages to a former teacher who argued the drugmaker’s Actos diabetes medicine caused his bladder cancer, in the company’s fifth loss in trials over the drug. Jurors in state court in Philadelphia deliberated more than two hours Friday before concluding that O...

Takeda Ordered to Pay Damages to Actos User

Takeda Pharmaceutical Co. was ordered by a jury Thursday to pay more than $2.3 million in damages to a former teacher who blamed the company’s Actos diabetes drug for causing his bladder cancer. Jurors in state court in Philadelphia deliberated more than eight hours over two days before finding that Osaka, Japan-based Takeda failed t...

Takeda Jury in Philadelphia Told Actos Responsible for Man’s Cancer

A Philadelphia jury was sent to deliberate Wednesday afternoon after being urged to find that Takeda Pharmaceuticals Inc. had willfully worked to obscure evidence linking the blockbuster diabetes drug Actos to an increased risk of bladder cancer. Miller Firm LLC attorney Michael Miller asked the jury during closing arguments to return ...

Pa. Judge Won’t Strike Actos Verdict Against Takeda

Pennsylvania judge has declined to overturn a $2 million verdict awarded in October to a plaintiff who claimed that the Takeda Pharmaceuticals Inc. drug Actos was a significant contributor to her developing bladder cancer. In an order docketed on Friday, Philadelphia Court of Common Pleas Judge Shelly Robins New rejected the company’...

Calif. Dept. of Health Says Tobacco Laws Should Cover E-Cigarettes

The California Department of Public Health said Wednesday (1/29/15) that laws aimed at protecting children and the public from traditional tobacco products should be expanded so that they include e-cigarettes, just one recommendation from a new report detailing the dangers and toxicity of so-called vaping devices. The report warns tha...

Studies Show Depakote During Pregnancy Linked to Autism

A Danish study found that mothers who took the anti-seizure medication Depakote during pregnancy were five times as likely to give birth to a child diagnosed with autism as mothers who did not take the drug. The study monitored over 665,000 Danish children from 1996 to 2006, 5, 500 of whom were diagnosed with autism. Of these, 508 were...

FDA Still Not Regulating E-Cigarettes

Electronic cigarettes, battery-powered devices that convert a solution of nicotine and other chemicals into a vapor that can be inhaled, or “vaped,” have the potential to wean a vast number of smokers off cigarettes. No burned tobacco leaves, no cancer-causing tar: a seemingly public health revolution in waiting. Right?  Um, not s...

Actos Caused Consumer’s Bladder Cancer, Philly Jury Hears

A Philadelphia jury heard opening arguments on Wednesday in a case against Takeda Pharmaceutical Co., the latest in a string of suits against the drugmaker, alleging that a retired high-school teacher developed bladder cancer after taking the diabetes drug Actos. Miller Firm LLC attorney Michael Miller told the jury that warnings issue...

Top 10 Takeaways on the Dangers of Indoor Tanning

The New York Times published a article today entitled, “Warning: That Tan Could Be Hazardous.” To summarize, the article makes the case that indoor tanning is a “serious public health concern.”  Here are the Top 10 Takeways from the article: According to a recent study by researchers at the University of Miami, there are more ...

60 Mesh Cases to Head to Trial

After a California court of appeals upheld a $5.5 million mesh verdict against C.R. Bard in November, the U.S District Court for the Southern District of West Virginia designated 60 vaginal mesh cases as “Miniwave 1” cases. These 60 cases will be tried in federal district courts around the country.  After the Southern District of...

Texas Legislature to Consider Banning E-Cigarette Sales to Minors

From The Houston Chronicle: Legislators in Texas, one of just nine states that permit the sale of e-cigarettes to minors, will consider banning such sales amid concerns about growing use of the “safer” alternative to smoking among youth. Even as the Texas Medical Association and Texas Public Health Coalition plan to lobby the 2015 Legi...

Survey Finds Teens Trending Toward E-cigarettes

More teens are trying out e-cigarettes than the real thing, according to the government’s annual drug use survey. Researchers were surprised at how many 8th, 10th and 12th graders reported using electronic cigarettes this year, even as regular smoking by teens dropped to new lows. Nearly 9 percent of 8th graders said they had used an e...

CDC Reports Tanning Bed Injuries Nearly 2,000 in 2012

Enter an indoor tanning booth today and you may find yourself with skin cancer decades down the road. But some painful consequences could be immediate. An estimated 1,957 indoor tanners landed in U.S. emergency rooms in 2012 after burning their skin or eyes, fainting or suffering other injuries, researchers from the federal Centers for...

NFL & NCAA Need to Bear Responsibility for Sports Concussions

As the College Football Playoff Committee caused a stir this weekend with its somewhat controversial picks of the teams that will be a part of the new College Football Playoff, last week we were somberly reminded, once again, of the physical toll that football-related concussions can take on players. Last Sunday, Ohio State football p...

Drug Can Repair Spinal Cord Injuries, Study Shows

The study on rats, published in the journal Nature, showed some degree of movement and bladder control could be restored.  The drug works by disrupting the “sticky glue” that prevents nerve cells from growing during an injury.  Further tests still need to take place, but the charity Spinal Research said “real progress” was being made...

Eli Lilly, Takeda Win Dismissal Of Ark. Taxpayer Actos Suit

A Louisiana federal judge on Thursday threw out a proposed class action alleging that Takeda Pharmaceutical Co. and Eli Lilly & Co. ripped off taxpayers by hiding the risks of their diabetes drug Actos, after the Arkansas Supreme Court ruled the drug was properly prescribed by doctors. In a two-page order granting the defendant’s mot...

Bard Can’t Avoid Its Part Of Pelvic Mesh Verdict

  A California appeals court on Wednesday affirmed a $5.5 million verdict against C.R. Bard Inc. and a gynecologist that found the two responsible for a woman’s injuries from a vaginal mesh implant in the first such case to go to trial. The panel rejected Bard’s argument that the negligence theories submitted to the jury were erron...

Takeda Ordered to Pay for Destroying Actos Files

Bloomberg is reporting that Takeda Pharmaceutical was ordered by a jury to pay $155,000 over its destruction of documents about its Actos diabetes medicine after the panel concluded the missing files blocked a man from proving his claims that the drug caused his cancer. Jurors in state court in Martinsburg, West Virginia, deliberated a...

Crumb Rubber Synthetic Turfs Possibly Toxic for Players

Various news outlets have reported on the dangers of the crumb rubber infill turf including NBC NEWS and the website THE POSTGAME. Recently, a few famous athletes including Abby Wambach, Kevin Durant, and Kobe Bryant voiced their opinions against synthetic turf fields. The issue is certainly significant as artificial turf fields are no...

Mesh Litigation Update: Boston Scientific on Trial in Miami, Florida

It will be up to the 9 person jury to decide, by the preponderance of the evidence, whether the Pinnacle Pelvic Floor Repair mesh kit, made by Boston Scientific, was defectively designed and whether the company failed to warn doctors through the product directions for use. The women claim negligence, defective product, a failure to war...

The Health Claims Of E-Cigarettes Are Going Up In Smoke

The sales pitch of electronic cigarette manufacturers seemed too good to be true. Could nicotine addicts around the world really get their fix whilst dodging the health risks of puffing away on cancer sticks? Sadly for smokers and “vapers,” the answer is far from clear. New evidence has emerged which suggests that E-Cigarettes can ...

It’s Easy to Overdose on Tylenol, Study Warns

The rise in prescriptions and non-prescription use of painkillers in the U.S. is no secret – in the past decade, prescriptions for opioids have skyrocketed by 300%, making them the most prescribed drugs in the country. And the consequences of that spike can be deadly, according to the latest report from Consumer Reports: nearly 17,00...

Stryker Agrees to Pay in Settlement for Hip Implant Suits

Stryker Corp. agreed to pay more than $1 billion to resolve lawsuits over thousands of hip implants recalled in 2012 after patients complained of pain, swelling and metal debris from the devices. Stryker will pay a base amount of $300,000 per case to patients who had the devices surgically removed, Kim Catullo, one of the company’s l...

J&J considering Settling Defective Hip Suit

Johnson & Johnson may pay more than $250 million to resolve suits over its ASR hip implants that were excluded from a $2.5 billion settlement of similar claims last year over the device’s failure, two people familiar with the accord said. J&J, the world’s largest seller of health-care products, is weighing whether to settle more than 1...

Actos Update: Takeda Lowers Punitive Damages Penalty

Takeda Pharmaceutical Co. and Eli Lilly & Co. won a more than a 99 percent cut in a $9 billion punitive damages award over claims the drugmakers hid the cancer risks of their Actos diabetes medicine. Jurors properly found officials of Osaka, Japan-based Takeda and Indianapolis-based Lilly intentionally hid the health risks of the drug ...

Boston Scientific Puts Aside Funds to Pay for Legal Expenses

Facing ongoing lawsuits over mesh products used to treat urinary incontinence, its 2006 acquisition of Guidant Corp., and tax issues with the IRS, Boston Scientific has now set aside nearly $1 billion to pay legal expenses. The Marlborough-based medical device company increased its litigation reserves by $139 million over the course of...

First Actos Bladder Cancer Suit In W.Va. Goes To Trial

The first trial in West Virginia state court over allegations that Takeda Pharmaceutical Co. Ltd.’s widely prescribed diabetes drug Actos causes bladder cancer begins today, featuring the same plaintiffs firm that has taken Actos cases to trial in four other states and secured three pro-plaintiff verdicts. The West Virginia trial comes...

Release Date for Mark Wahlberg’s “Deepwater Horizon” Movie Set

The movie based on the BP Deepwater Horizon oil disaster starring Mark Wahlberg is set for release September 30, 2016, according to producers Summit Entertainment. Entitled “Deepwater Horizon,” the film is based largely on a New York Times article titled “Deepwater Horizon’s final hour” which focuses on the 48 hours before the oil rig ...

Update: Takeda Ordered to Pay Actos User After Verdict is Reached

As mentioned in previous blog posts, we continue to follow the Actos bellwether trials as they occur across the country.  The latest Actos verdict occurred in Philadelphia, PA. in favor of the injured plaintiff. Takeda Pharmaceutical Co. was ordered by a jury to pay more than $2 million to a woman who claimed the company’s Actos di...

Takeda Accused of Putting Actos Profit Ahead of Safety

Takeda Pharmaceutical Co. was accused by a lawyer for a woman who blames Actos for her cancer of sacrificing safety for profit by failing to warn patients and doctors about the diabetes medicine’s risks. Executives at Osaka, Japan-based Takeda knew by 2004 that studies found links between Actos and cancer, and didn’t issue a warnin...

Endo to Settle Legal Claims Concerning Vaginal Mesh Products

Endo International PLC said it reached agreements to settle substantially all of the claims concerning vaginal mesh products sold by its American Medical Systems Holding Inc. unit. The drug and medical-device company said the agreements aren’t an admission of liability or fault. In April, Endo said it would pay about $830 million befor...

Good News: Takeda Hid Actos Bladder Cancer Risks, Philly Jury Hears

  An expert witness testifying on behalf of a woman who claims she developed bladder cancer after taking the diabetes drug Actos told a Philadelphia jury on Thursday that Takeda Pharmaceuticals Co. Ltd. had worked to suppress information about the cancer risks associated with the medication. Randall Tackett, a pharmacologist and toxico...

AAA Study Says 3 of 4 Kids’ Seats Are Installed Wrong

How safe is YOUR child’s safety seat? According to a new AAA survey, chances are it is not as safe as you thought. “Three out of four car seats today are installed incorrectly,” said Michele Harris, director of traffic safety culture, AAA – The Auto Club Group. “Too often, we see kids who are in a car seat that’s installed .....

5 Ways Tech Improves Car Safety

 DETROIT – Cellphones that warn drivers when people are crossing in front of them. Bicycles and cars that communicate with traffic lights. Sensors in cars that quickly alert other drivers to black ice, potholes or other hazards. A low-priced camera system that brings high-tech automatic braking to the masses. These life- or time-sav...

Boston Scientific Hit With Verdict In 1st Pelvic Mesh Loss

A Texas state jury blasted Boston Scientific Corp. with a $73.4 million verdict on Monday, finding that the company’s Obtryx-brand transvaginal sling was defectively designed and caused severe injuries, marking the first time the company has not prevailed in litigation over its pelvic mesh products. A spokeswoman from the law firm Fr...

Houston: Booming Economy But So Are Workplace Injuries

We may have a bustling economy in Texas, but is our city and state a safe place to work? According to new data released by the Occupational Safety and Health Administration (OSHA), the answer is a resounding “NO”. According to OSHA, Houston has the worst record in Texas, and Texas the worst in the country when it comes to workplace ......

J&J Federal Trial on Pelvic Mesh Devices Begins in West Virginia

Johnson and Johnson (JNJ), and its subsidiary, Ethicon, Inc., are going on trial this week in the US District Court for the Southern District of West Virginia, facing charges that one of its pelvic mesh devices, the TVT-O, was defective and that the company was negligent and fraudulent in its representation of the product. We Are Mesh ...

Judge Plans To Speed Up Vaginal Mesh Lawsuits, Trials

As the number of vaginal mesh lawsuits filed throughout the federal court system continues to increase, with many of the manufacturers of these controversial products making little progress toward settling the claims, the U.S. District Judge presiding over the litigation indicates that he will prepare a large number of cases to be “e...

FDA Doesn’t Man Up: Fails to Recall Vagina Mesh

The U.S. Food and Drug Administration has rejected a request from advocacy group Public Citizen to order recalls of existing surgical mesh products and ban their future sale, according to a letter released Monday that said a recent proposal to more rigorously review the devices is sufficient for now. In its response to a 2011 petition ...

Top Product Liability Verdicts Of 2014

The first half of 2014 produced at least five product liability verdicts topping $100 million, underscoring not only the ongoing vigor of long-running asbestos disputes, but the impact that an acrimonious discovery dispute can have on verdict size, as it did with the $6 billion award against Takeda Pharmaceuticals Co. Ltd. Here is a li...

Testosterone Use Doesn’t Increase Heart Risk, Study Finds

A study of 24,000 Medicare patients found that testosterone therapy didn’t increase the risk of heart attack, contrary to several earlier studies, and that it even lowered the risk of heart attack by about 30% in the group of men judged most likely to have one based on other factors. The findings are a boost for proponents of testoster...

SCOTUS Wants SG’s to Take On Generic-Drug Maker Liability

The U.S. Supreme Court on Monday asked the solicitor general to weigh in on Teva Pharmaceutical USA Inc.’s challenge to a California appeals court finding that the generic-drug maker can be held liable for injuries because it did not immediately update its warning label to match the brand-name equivalent version. In June 2013 the Cal...

Takeda, Lilly Say Prejudice Infected $9B Actos Verdict

Takeda Pharmaceutical Co. Ltd. and Eli Lilly & Co. argued Friday that the sheer size of the $9 billion punitive damages award they suffered in the bellwether personal injury trial over the diabetes drug Actos demonstrates the jury was inflamed by “passion and prejudice,” saying its verdict should be overturned. Reported as the sev...

ACTOS UPDATE: Takeda Destroyed Evidence In Cancer Suit, Judge Says

A Louisiana federal judge said on Friday, June 20th, that Takeda Pharmaceuticals Co. Ltd. intentionally destroyed evidence that would have helped the plaintiffs in a $9 billion bellwether lawsuit over claims the company hid the cancer risks of diabetes drug Actos to keep sales high. The ruling from U.S. District Judge Rebecca Doherty f...

Talcum Powder Like J&J’s Baby Powder Linked to Ovarian Cancer

Scientists have identified a disturbing link between ovarian cancer and talcum powder and other talcum-based products, which have been promoted for feminine hygiene uses in the U.S. and across the world for decades. A study published in the medical journal Cancer Prevention Research revealed a 24 percent increased risk of ovarian tumor...

UPDATE: Testosterone Replacement Therapy (TRT) Litigation

(1) NPR Discusses Testosterone & Potential Adverse Health Effects NPR recently discussed the popularity of testosterone replacement therapies, and how the The Food and Drug Administration is reassessing the safety of testosterone products. A spokesperson reiterated the agency’s own guidelines: None of the products approved by the FDA s...

Viagra May Increase Risk of Skin Cancer

Following the publication of a recent study that found a possible link between Viagra and melanoma skin cancer, it appears that Pfizer may face product liability lawsuits over the failure to adequately warn about the potential risks associated with their popular erectile dysfunction drug. According to a study published in this month’...

Pradaxa Litigation Set for Settlement

Boehringer Ingelheim Pharmaceuticals, Inc. and its affiliated companies, and the Plaintiffs’ Steering Committee appointed by a federal judge to coordinate litigation involving Pradaxa in In Re Pradaxa (Dabigatran Etexilate) Products Liability Litigation, MDL No. 2385, today negotiated a settlement program to resolve the claims of app...

Takeda Wins Las Vegas Lawsuit Over Diabetes Drug Actos

  A Nevada state jury found for Takeda Pharmaceutical Co. Ltd. on Thursday after a months-long trial in which two elderly women claimed the company’s diabetes drug Actos causes bladder cancer, a victory that follows Takeda’s astounding $6 billion loss earlier this year in a federal suit over the same drug. The jury delivered its verdic...

ACTOS Updates

(1)      Takeda Avoids Another Big Loss In Ill. Actos Cancer Trial A jury on Thursday cleared Takeda Pharmaceutical Co. Ltd. of liability in the first trial among thousands of Illinois lawsuits blaming the diabetes drug Actos for causing bladder cancer, following a multibillion-dollar verdict against the drugmaker last month in Lo...

115 of 117 Avandia Cases in MDL Dismissed Due to SOL Problems

U.S. District Judge Cynthia M. Rufe, a Pennsylvania federal judge, dismissed 115 out of 117 cases that GlaxoSmithKline LLC (GSK) argued were outside the statute of limitations in the multidistrict litigation over injuries caused by diabetes drug Avandia.  The ruling was announced on May 16, 2014. Rufe said that all but two of the case...

Bayer & Doctor Lose: Verdict Awards Injured Woman in Yasmin Lawsuit

A jury has awarded $14 million to a suburban Chicago woman who sued her doctor over a debilitating stroke she suffered after taking the birth control drug Yasmin. Lawyers for Mariola Zapalski, of Elmwood Park, say the stroke occurred 13 days after she began taking the drug, paralyzing her left side and causing permanent brain injury. A...

Actos Update: Las Vegas Judge Denies Attempt to Remove Herself

Actos continues to be in the news, and the national focus now shifts to the Actos trial in Las Vegas that our blog has reported on previously. A Las Vegas judge will not remove herself from a civil case filed by two women against the maker of the diabetes drug Actos. “I absolutely see no evidence that there’s any appearance ... Rea...

Actos Verdict: Jury Orders Takeda, Eli Lilly To Pay Damages

Takeda Pharmaceutical Co. and Eli Lilly & Co. were ordered to pay a combined $9 billion in punitive damages after a federal court jury found they hid the cancer risks of their Actos diabetes medicine in the first U.S. trial of its kind. Osaka, Japan-based Takeda was ordered to pay $6 billion by the jury yesterday in Lafayette, Louisian...

Actos Trial Continues in Nevada

After three and a half weeks of selecting a jury from a pool of 400 Clark County citizens, the Actos trial continues to play out in Las Vegas, Nevada.  The case is noteworthy because the plaintiffs, Bertha Triana and Delores Cipriano, are seeking the largest jury award in Nevada history.  Japanese pharmaceutical giant Takeda is accus...

“Low T” Case Filed in California Against Auxilium’s Testim Drug

A 58-year-old California man who suffered injuries after using the testosterone replacement therapy (“TRT”) drug Testim has sued manufacturer Auxilium Pharmaceuticals Inc., claiming it coordinated a massive ad campaign to aggressively promote the need for its product while failing to warn users of life-threatening side effects. In ...

New Study Suggests GSK’s Paxil May Cause Breast Cancer

The Los Angeles Times is reporting how a team of researchers from the City of Hope in Duarte  has developed a speedy way to identify drugs and chemicals that can disrupt the balance of sex hormones in human beings and influence the development and progress of diseases such as breast cancer. In a trial screening of 446 drugs in wide .....

Study of Drug for Blood Clots Caused a Stir, Records Show

The New York Times is reporting Boehringer Ingelheim, makers of the blood-thinning drug Pradaxa, were so worried that an internal research paper would damage drug sales that some employees not only pressured the author to revise it, but suggested it should be quashed altogether, according to newly unsealed legal documents. The document...

Takeda Jury Can Hear Claims Over Destroyed Actos Files

Bloomberg News is reporting Takeda Pharmaceutical Co. must let a jury hear claims that it intentionally destroyed files related its Actos diabetes drug, a judge ruled before the first federal trial over allegations the pills cause bladder cancer. Officials of Osaka, Japan-based Takeda admitted they can’t find files compiled by 46 cur...

Takeda, makers of Actos, Scraps Development of Type 2 Diabetes Drug

Japanese pharmaceutical company Takeda is dropping plans to develop diabetes drug fasiglifam (TAK-875) because clinical trials showed participants developed dangerous side effects, including possible liver damage. This comes as a blow for the drugmaker as it scrambles to find another drug to take the place of its once best-selling Type...